Amyloid Pathology and Protein Kinase C (PKC): Possible Therapeutics Effects of PKC Activators
Amyloid β-protein (Aβ) is one of the most studied peptides in human neurodegenerative disorders. Although much has been learned about the biochemistry of this peptide, fundamental questions such as when and how the Aβ becomes pathologic remain unanswered. In this article we review the recent finding...
Saved in:
Main Authors: | Ana Olariu (Author), Kiyofumi Yamada (Author), Toshitaka Nabeshima (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2005-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Activators and Inhibitors of Protein Kinase C (PKC): Their Applications in Clinical Trials
by: Takahito Kawano, et al.
Published: (2021) -
Features and mechanisms of propofol-induced protein kinase C (PKC) translocation and activation in living cells
by: Soma Noguchi, et al.
Published: (2023) -
Investigation of the inhibitory effects of HA-1077 and Y-32885 on the translocation of PKCβI, PKCβII and PKCζ in human neutrophils
by: Xavier Siomboing, et al.
Published: (2001) -
A Selective Inhibitor of Cardiac Troponin I Phosphorylation by Delta Protein Kinase C (δPKC) as a Treatment for Ischemia-Reperfusion Injury
by: Nir Qvit, et al.
Published: (2022) -
HIV latency reversal using designed PKC modulators
by: M.D. Marsden, et al.
Published: (2017)